These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
170 related items for PubMed ID: 14513059
1. BCR-ABL with an e6a2 fusion in a CML patient diagnosed in blast crisis. Schultheis B, Wang L, Clark RE, Melo JV. Leukemia; 2003 Oct; 17(10):2054-5. PubMed ID: 14513059 [No Abstract] [Full Text] [Related]
2. Absence of bcr/abl gene in single hemopoietic progenitors in some patients with chronic myelogenous leukemia. Misawa M, Maeda H, Hara H, Yamamoto Y, Furuyama J. Stem Cells; 1993 Nov; 11(6):536-42. PubMed ID: 7509222 [Abstract] [Full Text] [Related]
3. Differences and similarities in kinetics of BCR-ABL transcript levels in CML patients treated with imatinib mesylate for chronic or accelerated disease phase. Moravcová J, Zmeková V, Klamová H, Voglová J, Faber E, Michalová K, Rabasová J, Jarosová M. Leuk Res; 2004 Apr; 28(4):415-9. PubMed ID: 15109543 [Abstract] [Full Text] [Related]
4. A multiplex PCR for improved detection of typical and atypical BCR-ABL fusion transcripts. Burmeister T, Reinhardt R. Leuk Res; 2008 Apr; 32(4):579-85. PubMed ID: 17928051 [Abstract] [Full Text] [Related]
5. BCR and BCR-ABL regulation during myeloid differentiation in healthy donors and in chronic phase/blast crisis CML patients. Marega M, Piazza RG, Pirola A, Redaelli S, Mogavero A, Iacobucci I, Meneghetti I, Parma M, Pogliani EM, Gambacorti-Passerini C. Leukemia; 2010 Aug; 24(8):1445-9. PubMed ID: 20520635 [Abstract] [Full Text] [Related]
6. Bcr-abl mRNA expression in patients with chronic myeloproliferative disorders--absence of bcr-abl fused clone except chronic myelocytic leukemia. Nakata Y. Hiroshima J Med Sci; 1993 Jun; 42(2):67-71. PubMed ID: 8253600 [Abstract] [Full Text] [Related]
7. Description of a new BCR-ABL point mutation in a CML patient with evolution to lymphoid blast crisis. Hokama PO, Capannacci J, Hokama NK, Cliquet MG, Souza MP, Mauad MA, Colturato VA. Leuk Res; 2010 Apr; 34(4):e106-7. PubMed ID: 19931180 [No Abstract] [Full Text] [Related]
8. Differential display analysis of mRNAs in chronic myelogenous leukaemia. el-Awady MK, Abdalla NM, Salem AM, Samir S, Nour AM. East Mediterr Health J; 2001 Apr; 7(4-5):707-15. PubMed ID: 15332769 [Abstract] [Full Text] [Related]
9. Imatinib induces a cytogenetic response in blast crisis or interferon failure chronic myeloid leukemia patients with e19a2 BCR-ABL transcripts. Lee JJ, Kim HJ, Kim YJ, Lee S, Hwang JY, Kim YL, Kim DW. Leukemia; 2004 Sep; 18(9):1539-40. PubMed ID: 15284852 [No Abstract] [Full Text] [Related]
11. Molecular monitoring of response to imatinib (Glivec) in CML patients pretreated with interferon alpha. Low levels of residual disease are associated with continuous remission. Paschka P, Müller MC, Merx K, Kreil S, Schoch C, Lahaye T, Weisser A, Petzold A, König H, Berger U, Gschaidmeier H, Hehlmann R, Hochhaus A. Leukemia; 2003 Sep; 17(9):1687-94. PubMed ID: 12970765 [Abstract] [Full Text] [Related]
12. AID expression is correlated with Bcr-Abl expression in CML-LBC and can be down-regulated by As2O3 and/or imatinib. Liu Z, Wu X, Duan Y, Wang Y, Shan B, Kong J, Ma X, Bao Y. Leuk Res; 2011 Oct; 35(10):1355-9. PubMed ID: 21570118 [Abstract] [Full Text] [Related]
13. Quantitative real-time reverse-transcription polymerase chain reaction for diagnosis of BCR-ABL positive leukemias and molecular monitoring following allogeneic stem cell transplantation. Neumann F, Herold C, Hildebrandt B, Kobbe G, Aivado M, Rong A, Free M, Rössig R, Fenk R, Schneider P, Gattermann N, Royer-Pokora B, Haas R, Kronenwett R. Eur J Haematol; 2003 Jan; 70(1):1-10. PubMed ID: 12631253 [Abstract] [Full Text] [Related]
14. Isolated central nervous system relapse after nine years of complete molecular remission in a lymphoid blast crisis of chronic myeloid leukemia treated with imatinib. Breccia M, Santopietro M, Cannella L, Federico V, Loglisci G, Serrao A, Petrucci L, Salaroli A, Nanni M, De Propris MS, Diverio D, Alimena G. Leuk Res; 2011 Jun; 35(6):e91-2. PubMed ID: 21316103 [No Abstract] [Full Text] [Related]
15. e6a2 BCR/ABL1 fusion with cryptic der(9)t(9;22) deletions in a patient with chronic myeloid leukemia. Roti G, La Starza R, Gorello P, Gottardi E, Crescenzi B, Martelli MF, Mecucci C. Haematologica; 2005 Aug; 90(8):1139-41. PubMed ID: 16079118 [Abstract] [Full Text] [Related]
16. Appearance of acute leukemia-associated P190BCR-ABL in chronic myelogenous leukemia may correlate with disease progression. Dhingra K, Talpaz M, Kantarjian H, Ku S, Rothberg J, Gutterman JU, Kurzrock R. Leukemia; 1991 Mar; 5(3):191-5. PubMed ID: 2013978 [Abstract] [Full Text] [Related]
17. Comprehensive analysis of BCR-ABL transcript types in Korean CML patients using a newly developed multiplex RT-PCR. Goh HG, Hwang JY, Kim SH, Lee YH, Kim YL, Kim DW. Transl Res; 2006 Nov; 148(5):249-56. PubMed ID: 17145570 [Abstract] [Full Text] [Related]
18. Possible correlation between fusion pattern of BCR/ABL mRNA and clinical response to alpha-interferon in chronic myelogenous leukemia. Inoue T, Tojo A, Tsuchimoto D, Okamoto S, Ogura H, Tani K, Ozawa K, Shibuya M, Asano S. Leukemia; 1992 Sep; 6(9):948-51. PubMed ID: 1518306 [Abstract] [Full Text] [Related]
19. bcr/abl mRNA in leukemic blasts of an unusual patient with acute lymphoblastic leukemia followed after 5-year remission by chronic myelogenous leukemia in blast crisis. Fujie H, Tsuchiya S, Morita S, Itano M, Yambe T, Ohasi Y, Minegishi N, Minegishi M, Satou T, Konno T. Leukemia; 1994 Sep; 8(9):1592-5. PubMed ID: 8090037 [Abstract] [Full Text] [Related]
20. Detection of bcr-abl fusion mRNA in chronic myelogenous leukemia by reverse transcription polymerase chain reaction using nested primers. Furukawa Y, Ju SL, Cho HL, Tatsumi N. Osaka City Med J; 1993 Jun; 39(1):35-45. PubMed ID: 7694218 [Abstract] [Full Text] [Related] Page: [Next] [New Search]